Search Results - Januszka, Jenna E

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Assessing pharmacy resident success via oral board examinations: Should there be a standard?

    Assessing pharmacy resident success via oral board examinations: Should there be a standard? by Januszka, Jenna E, Jarrett, Jennie B

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?

    Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment? by Januszka, Jenna, Drwiega, Emily, Badowski, Melissa

    Published in HIV/AIDS (Auckland)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Expanding expedited partner therapy and HIV prophylaxis in the emergency department

    Expanding expedited partner therapy and HIV prophylaxis in the emergency department by Mercer, Kevin J, Brizzi, Marisa B, Burhoe, Devon N, Senn, Joshua M, Rohani, Roxane, Nowicki, Diana Nicole, Januszka, Jenna E, Wordlaw, Rudijah, Durham, Spencer H

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Bictegravir/Emtridtabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?

    Bictegravir/Emtridtabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment? by Januszka, Jenna E, Drwiega, Emily N, Badowski, Melissa E

    Published in HIV/AIDS (Auckland)
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    1518. Prevalence of Integrase Inhibitor Resistance within an Urban Clinic Network After Adoption as First-line Therapy

    1518. Prevalence of Integrase Inhibitor Resistance within an Urban Clinic Network After Adoption as First-line Therapy by Januszka, Jenna E, Drweiga, Emily N, Badowski, Melissa E

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy

    2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy by Januszka, Jenna, Drwiega, Emily N, Burgos, Rodrigo M, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: